medigraphic.com
ISSN 1527-3172 (Electronic)

2021, Number 2

<< Back Next >>

MEDICC Review 2021; 23 (2)

Genodermatoses in Las Tunas Province, Cuba, 1989–2019

Velázquez-Ávila Y, Valenciano-Rodríguez CR

Language: English
References: 46
Page: 34-41
PDF size: 150.14 Kb.


ABSTRACT

INTRODUCTION Genodermatoses are a group of genetic diseases that affect the skin and adjoining tissues. They represent 15% of genetic diseases worldwide. Cuba established a National Program for the Diagnosis, Care and Prevention of Genetic Diseases and Congenital Abnormalities in 1980, which was implemented in Las Tunas in 1989. In 2010, a specialized multidisciplinary provincial service for genodermatoses patients was established in Las Tunas province. Several studies in Las Tunas show that genodermatoses represent 22.2% of genetic diseases; the most common are ichthyosis (16.7%), mastocytosis (11.7%), and neurofibromatosis (8.3%). Children aged <12 years are the most affected (61.6%).
OBJECTIVE Describe genodermatoses in Las Tunas Province, Cuba, since the implementation of the National Program for the Diagnosis, Care, and Prevention of Genetic Diseases and Congenital Abnormalities, and after the creation of a specialized multidisciplinary provincial service for genodermatoses patients.
METHODS We conducted an observational, descriptive, retrospective study in 249 patients diagnosed with some type of genodermatosis who received care in Las Tunas during 1989–2019. Variables considered were: type of genodermatosis, complications, deaths and geographic location by municipality. We studied prevalence rates (1989–2019), incidence rates (2010–2019), proportion of complications, survival rates, and types of genodermatosis diagnosed by municipality in two periods (1989–2009 and 2010–2019) one before, and one after the implementation of a targeted multidisciplinary provincial care service.
RESULTS The general prevalence rate of genodermatoses in Las Tunas Province was 46.51 per 100,000 population. The forms with the highest prevalence rates were neurofi bromatosis type 1 (13.6 per 100,000 population), classical Ehlers-Danlos syndrome (7.1 per 100,000), ichthyosis vulgaris (5.0 per 100,000) and cutaneous mastocytosis (2.4 per 100,000). The highest incidence rates coincided with the conditions with the highest prevalence: neurofibromatosis type 1 (81.5 per 1000 cases in 2013), classical Ehlers- Danlos syndrome (44.4 per 1000 cases in 2013) and ichthyosis vulgaris (52 per 1000 cases in 2010). From 1989–2009, patients presented a greater frequency of complications, at 40% (22/55) than from 2010–2019 at 21.1% (41/194). Pyodermitis was the most common during the study period (1989–2019), with 29.1% (16/55). Survival was high, at 98.0% (only 5 deaths in 2009, 2010, 2011, 2012, and 2015, and were no deaths during other years) in the study period. The greatest share of genodermatosis cases was registered in the municipality of Majibacoa (0.07%), and consanguinity was found in cases of epidermolysis bullosa, Herlitz type and xeroderma pigmentosum.
CONCLUSION In Las Tunas Province, Cuba, genodermatoses as a whole are not rare diseases. Those with the highest prevalence and incidence rates are neurofibromatosis type 1, classical Ehlers-Danlos syndrome and ichthyosis vulgaris. After implementation of the specialized multidisciplinary provincial service for genodermatoses patients within Cuba’s National Program for the Diagnosis, Care, and Prevention of Genetic Diseases and Congenital Abnormalities, in addition to the active screening implemented by this Program, more cases were diagnosed, and a lower proportion of complications and a higher survival rates were recorded.


REFERENCES

  1. Manzur J. Genodermatosis. In: Dermatología.Havana: Editorial Ciencias Médicas; 2002. p.48–67. Spanish.

  2. Arenas R. Dermatología. Atlas, diagnóstico ytratamiento [Internet]. 6th ed. México: McGraw-Hill Interamericana; 2017. Chapter 54, Neurofibromatosis; [cited 2020 May 29]; p. 336–7.Available at: https://accessmedicina.mhmedical.com/content.aspx?bookid=1538§ionid=102305123&jumpsectionID=102305146. Spanish.

  3. Morice Picard F. Genética en dermatología [Internet].Madrid: Elseiver Masson SAS; 2017 [cited2020 May 29]. p. 51. Available at: https://www.em-consulte.com/es/article/1122358/genetica-en-dermatologia. Spanish.

  4. Penago Homero G. Prevención y manejo de lasenfermedades genéticas de la piel en Panamá[master’s thesis] [Internet]. Florida: Atlantic InternationalUniversity; 2006 [cited 2020 May 28].Available at: http://www.aiu.edu/publications/student/spanish/prevencion-y-manejo-de-las-enfermedades-geneticas-de-la-piel-en-panama.htm. Spanish.

  5. James W, Berger T, Dirk E. Genodermatosesand Congenital Anomalies. Clinical Dermatology.In: Andrews’ Diseases of the Skin [Internet].13th ed. New York: Elseiver; 2019 [cited 2020Jun 3]; p. 547–86. Available at: https://www.eu.elsevierhealth.com/andrews-diseases-of-the-skin-9780323547536.html

  6. James W, Berger T, Dirk E. Abnormalities of dermalfi brous and elastic tissue. Clinical Dermatology.In: Andrews’ Diseases of the Skin [Internet].13th ed. New York: Elseiver; 2019 [cited 2020Jun 3]; p. 508–10. Available at: https://www.eu.elsevierhealth.com/andrews-diseases-of-the-skin-9780323547536.html

  7. Acuña Aguilarte PM. Xeroderma pigmentoso. In:Pediatría. Diagnóstico y tratamiento. Havana: EditorialCiencias Médicas; 2016. p. 532. Spanish.

  8. Barbel P, Brown S, Peterson K. Identifi cation ofhipomelanosis of Ito in pediatric primary care.J Ped Health Care [Internet]. 2015 Nov–Dec[cited 2020 May 29];29(6):551–4. Available at:https://linkinghub.elsevier.com/retrieve/pii/S0891-5245(15)00004-8

  9. Patterson J. Disorder of epidermal maturationand keratinization. In: Weedon’s Skin Pathology[Internet]. 4th ed. New York: Elseiver; 2015 Jan12 [cited 2020 Jun 3]; p. 281–320. Available at:https://www.elsevier.com/books/weedons-skin-pathology/patterson/978-0-7020-5183-8

  10. Fleury de Lemos Pereira D, Lopes AraujoE, Duarte Patuzzo FV. Perfi l do pacientealbino com visão subnormal e melhoria daacuidade visual com a adaptação de recursosópticos e/ou eletrônicos. Rev Bras Oftalmol[Internet]. 2016 Nov–Dec [cited 2020Jun 6];75(6):456–60. Available at: https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802016000600456. Portuguese,English.

  11. Ocaña Jaramillo S, Del Boz J, Vera CasañoA. Incontinencia pigmenti. Estudio descriptivode la experiencia en dos centros hospitalarios.An Pediatr [Internet]. 2020 Jan [cited 2020 Jun1];92(1):3–12. Available at: https://www.analesdepediatria.org/es-incontinencia-pigmenti-estudio-descriptivo-experiencia-articulo-S1695403319301705?referer=buscador. Spanish.

  12. Arango J, Delgado J, Saldarriaga W. Esclerosistuberosa, diagnóstico fetal y materno. Rev ChilObstet Ginecol [Internet]. 2015 Dec [cited 2020Jun 1];80(6):475–80. Available at: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0717-75262015000600007. Spanish.

  13. Prodinger C, Reichelt J, Bauer JW, Laimer M.Epidermolysis bullosa: advances in researchand treatment. Exp Dermatol [Internet]. 2019 Oct[cited 2020 Jun 1];28(10):1176–89. Available at:https://doi.org/10.1111/exd.13979

  14. Pingault V, Ente D, Dastot-Le Moal F, GoossensM, Marlin S, Bondurand N. Review and updateof mutations causing Waardenburg syndrome.Hum Mutat [Internet]. 2010 Apr [cited 2020 Jun1];31(4):391–406. Available at: https://onlinelibrary.wiley.com/doi/abs/10.1002/humu.21211

  15. Dorticós Balea A, Zaldívar Vaillant T, FalcónLincheta L. Frecuencia de los distintos tipos degenodermatosis en la Ciudad de la Habana enlos años 1980 a 1986. Digitalización [Internet].1989 Jan–Feb [cited 2020 Jun 3];61(1):75–80.Available at: http://fi les.sld.cu/digitalizacion-bmn/fi les/2017/01/S0034-7531.1989.0001.0008.pdf.Spanish.

  16. Campo Díaz MC, Hernández González JL, GatoSantiesteban Y, Valdés Sojo C, Fortún Prieto A.Evaluación de la hemostasia en niños con Síndromede Ehlers-Danlos tipo III. Rev CubanaHematol Inmunol Hemoter [Internet]. 2014 Apr–Jun [cited 2020 Jun 3];30(2). Available at: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892014000200007. Spanish.

  17. Orraca Castillo M. Caracterización epidemiológica,clínica y genética de la neurofi bromatosis1 en la provincia Pinar del Río [doctoral thesis][Internet]. [Havana] University of Medical Sciencesof Havana; 2017 May 10 [modifi ed 2017 Sep6; cited 2020 Jun 3]. 200 p. Available at: http://tesis.sld.cu/index.php?P=FullRecord&ID=238&ReturnText=Search+Results&ReturnTo=index.php%3FP%3DAdvancedSearch%26Q%3DY%26FK%3Dneurofi bromatosis. Spanish.

  18. Carcasés Carcasés E, Orive Rodríguez NM,Romero Portelles LC, Silva González GK. Enfermedadesgenéticas más frecuentes en pacientesatendidos en consulta de genética clínica. RevZoilo Marinello [Internet]. 2015 Mar [cited 2020Jun 3];40(3). Available at: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/84. Spanish.

  19. World Health Organization [Internet]. Geneva:World Health Organization; c2020. Genes andhuman disease. Human Genomics in GlobalHealth; 2017 [updated 2020 Nov 12; cited 2020May 28]. Available at: http://www.who.int/genomics/public/geneticdiseases/en/index2.html

  20. Lantigua Cruz A. Enfermedades genéticas ydefectos congénitos en la infancia. In: Pediatría.Diagnóstico y tratamiento. Havana: EditorialCiencias Médicas; 2016. p. 97–114. Spanish.

  21. World Health Organization [Internet]. Geneva:World Health Organization; c2020. Control de lasenfermedades genéticas. Informe de la Secretaría.Consejo Ejecutivo; 2005 Apr 21 [cited 2020May 28]. Available at: http://apps.who.int/gb/archive/pdf_fi les/EB116/B116_3-sp.pdf. Spanish.

  22. Roblejo Balbuena H, Marcheco Teruel B.Genetics and genomics medicine in Cuba. MolGenet Genomic Med [Internet]. 2017 May 21[cited 2020 May 28];5(3):196–201. Available at:https://onlinelibrary.wiley.com/doi/full/10.1002/mgg3.299

  23. Marcheco Teruel B, Rojas Betancourt I, LantiguaCruz A, Benítez Cordero Y, Suárez Besil B.Manual de normas y procedimientos. Serviciosde Genética Médica en Cuba. Havana: EditorialCiencias Médicas; 2017. p. 105–6. Spanish.

  24. Velázquez Ávila Y, Tamayo Mariño K, MoralesSolís M, González Saker AG, García López R.Alteraciones genéticas cutáneas diagnosticadasen la infancia, Las Tunas 2010-2012. Rev ZoiloMarinello [Internet]. 2014 Apr [cited 2020 Jun3];39(4). Available at: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/261. Spanish.

  25. Zegpi-Trueba MS, Hasbún Acuña P, Berroeta-Mauriziano D. Mastocitosis cutánea: reporte deun caso. Rev Chil Pediatr [Internet]. 2016 Jun[cited 2020 Jun 6];87(3):204–7. Available at:https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0370-41062016000300010. Spanish.

  26. De León Ojeda NE. La genética clínica, de laobservación a su aplicación. Rev Cubana Pediatr[Internet]. 2014 Apr–Jun [cited 2020 Jun6];86(1):1–4. Available at: http://scielo.sld.cu/pdf/ped/v86n1/ped01114.pdf. Spanish.

  27. National Bureau of Statistics (CU) [Internet].Havana: National Bureau of Statistics (CU);c2021. Provincia Las Tunas; 2019 [cited 2020Jun 3]. Available at: http://www.onei.gob.cu/sites/default/fi les/anuario_est_provincial/las_tunasok.pdf. Spanish.

  28. Lizaraso Caparó F, Benavides Zúñiga A. ÉticaMédica. Horiz Med Lima [Internet]. 2018 Oct–Dec [cited 2020 Jun 3];18(4):4–8. Available at:http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1727-558X2018000400001.Spanish.

  29. Lieberman M, Ricer R, editors. Bioquímica,biología molecular y genética [Internet]. 6th ed.New York: Lippincott W & W; 2015 [cited 2020Jun 4]. Available at: https://www.ovid.com/product-details.13900.html

  30. López Lambán A, Calatayud Madonado V, Casadode Frías E, Tobajas Asensio LM. La OMSha identifi cado 5.000 enfermedades raras, sincontar las ultra raras. Redacción Médica [Internet].2018 Mar 26 [cited 2020 Jun 4];Sanidadprivada:[about 3 p.]. Available at: https://www.redaccionmedica.com/secciones/privada/la-oms-ha-identificado-5-000-enfermedades-raras-sin-contar-las-ultra-raras-7846. Spanish.

  31. Carbajal Rodríguez L, Navarrete Martínez JI.Enfermedades raras. Acta Pediatr Mex [Internet].2015 [cited 2020 Jun 4];36(5):369–73. Availableat: https://ojs.actapediatrica.org.mx/index.php/APM/article/view/1057. Spanish.

  32. Online Mendelian Inheritance in Man (OMIM)[Internet]. Maryland: John Hopkins University;c1966–2021. Statistics. Neurofi bromatosis, TypeI; NF1; [published 1986 Jun 2; updated 2020 Apr14; cited 2020 Jun 4]. Available at: https://omim.org/entry/162200

  33. Ghali N, Sobey G, Burrows N. Ehlers-Danlossyndromes. BMJ [Internet]. 2019 Sep 18 [cited2020 Jul 1];366:l4966. Available at: https://www.bmj.com/lookup/pmidlookup?view=long&pmid=31533917

  34. Wiesmann T, Jais C. Recomendaciones parala anestesia de pacientes con síndrome deEhlers-Danlos [Internet]. Nümberg (GR):ORPHAN ANESTHESIA; 2019 Nov [cited2020 Jul 1]. Available at: https://www.orphananesthesia.eu/en/component/finder/search.html?q=Recomendaciones+sobre+anestesia+para+pacientes+que+sufren+S%C3%ADndrome+de+Ehlers-Danlos&Itemid=137. Spanish.

  35. Vega Almendra N, Aranibar Duran L. Ictiosishereditaria: desafío diagnóstico y terapéutico.Rev Chil Pediatr [Internet]. 2016 Jun [cited 2020Jul 29];87(3):213–23. Available at: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0370-41062016000300013. Spanish.

  36. Valdés González JL, Solís Cartas U, ValdésGonzález EM. Mastocitosis cutánea. Un casosingular. Rev Haban Cienc Méd [Internet].2016 Jan–Feb [cited 2020 Jul 29];15(1):64–71.Available at: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2016000100008&lng=es. Spanish.

  37. Torres Rives B, Portal Miranda JA, MederosBenítez Y, Martínez Téllez G, Lantigua Cruz A,Rodríguez Pelier C, et al. Respuesta inmunehumoral en pacientes cubanos con genodermatosisatendidos en el hospital pediátrico Juan Manuel Márquez. Rev Cubana Gen Comunit[Internet]. 2015 [cited 2020 Aug 6];9(3):36–46.Available at: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=68815. Spanish.

  38. Online Mendelian Inheritance in Man (OMIM)[Internet]. Maryland: John Hopkins University;c1966–2021. Statistics. Epidermolysis bullosa,junctional, Herlitz type; [published 1986 Jun 3;updated 2018 Feb 7; cited 2020 Jun 6]. Availableat: https://omim.org/entry/226700

  39. Orphanet [Internet]. Paris: Institut Nationale de laSanté et de la Recherche Médicale (FR); c2021.Enfermedades raras. Búsqueda. Síndrome delcuerno occipital; [updated 2021 Mar 3; cited 2020Aug 6]. Available at: https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=ES&Expert=198.Spanish.

  40. Reginato A. Ehlers Danlos syndrome. In: Ferri’sClinical Advisor [Internet] New York: Elsevier; 2020[cited 2020 Aug 6]; p. 482e2–482e12. Availableat: https://www.elsevier.com/books/ferris-clinical-advisor-2020/ferri/978-0-323-67254-2

  41. Dos Santos Martins TG, Fontes de Azevedo CostaAL, Gonçalves dos Santos Martins T. Rothmundsyndrome. Rev Bras Oftalmol [Internet].2015 Nov–Dec [cited 2020 Aug 6];74(6):390–2.Available at: https://www.researchgate.net/publication/283663906. English, Portuguese.

  42. Online Mendelian Inheritance in Man (OMIM)[Internet]. Maryland: John Hopkins University;c1966–2021. Statistics. Rothmund-Thomsonsyndrome, Type 1; RTS1; [published 2019 Oct15; cited 2020 Aug 6]. Available at: https://omim.org/entry/618625

  43. Diez de Medina JC, Antezana EC, SanguezaM. Síndrome de Netherton: comunicación dedos pacientes. Dermatología CMQ [Internet].2015 [cited 2020 Aug 6];13(4):314–7. Availableat: http://www.medigraphic.com/pdfs/cosmetica/dcm-2015/dcm154f.pdf. Spanish.

  44. Online Mendelian Inheritance in Man (OMIM)[Internet]. Maryland: John Hopkins University;c1966–2021. Statistics. Netherton syndrome;NETH; [published 1986 Jun 4; updated 2019 Apr8; cited 2020 Aug 6]. Available at: https://omim.org/entry/256500

  45. Duat Rodríguez A. Características fenotípicas ygenéticas en la neurofi bromatosis tipo 1 en la edadpediátrica [doctoral thesis] [Internet]. [Madrid] UniversidadAutónoma de Madrid; 2015 [cited 2020 Aug8]. 155 p. Available at: https://repositorio.uam.es/bitstream/handle/10486/667203/duat_rodriguez_anna.pdf?sequence=1. Spanish.

  46. Abarca Barriga HH, Chávez Pastor M, TrubnykovaM, La Serna-Infantes JE, Poterico JA. Factoresde riesgo en las enfermedades genéticas.Acta Méd Perú [Internet]. 2018 Jan [cited 2020Aug 8];35(1):43–50. Available at: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1728-59172018000100007. Spanish.




2020     |     www.medigraphic.com